Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That Is Refractory to Radioactive Iodine (RAI) Treatment
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2200
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
Elsevier BV